Status:

COMPLETED

A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of MK1006

Eligibility Criteria

Inclusion

  • Participant is between 18 and 55 years of age. Participants up to 65 years of age may be enrolled in Panels B and C
  • Female participants must be postmenopausal or otherwise unable to have children
  • Participant has a body mass index (BMI) less than or equal to 42 kg/m\^2 at the screening visit
  • Participant has type 2 diabetes and is being treated with either diet and exercise or a single oral anti-hyperglycemic medication. For Panels B and C, participant may be treated with combination oral anti-hyperglycemic medications
  • Participant is willing to follow the American Heart Association (AHA) diet and exercise program throughout the study
  • Participant is a nonsmoker or has not used nicotine-containing products for 6 months prior to study start

Exclusion

  • Participant has a history of stroke, seizures, or other neurological disorders
  • Participant has a recent history of eye infection or other inflammatory eye conditions
  • Participant has glaucoma or is blind
  • Participant has had eye surgery within 6 months of study start (Lasik is permitted)
  • Participant has type 1 diabetes
  • Participant cannot stop taking any of their current prescription or non-prescription medications during the study
  • Participant consumes more than 3 alcoholic beverages per day
  • Participant consumes more than 6 caffeinated beverages per day
  • Participant has had major surgery or has donated blood within 4 weeks of study start
  • Participant has multiple and/or severe allergies to drugs or food

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00757601

Start Date

April 1 2008

End Date

December 1 2008

Last Update

February 5 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED) | DecenTrialz